Social oocyte freezing: A survey among Singaporean female medical students

Size: px
Start display at page:

Download "Social oocyte freezing: A survey among Singaporean female medical students"

Transcription

1 bs_bs_banner doi: /jog J. Obstet. Gynaecol. Res. Vol. 40, No. 5: , May 2014 Social oocyte freezing: A survey among Singaporean female medical students Shu Qi Tan 1, Andy Wei Keat Tan 1, Matthew Sie Kuei Lau 2, Heng Hao Tan 2 and Sadhana Nadarajah 2 Departments of 1 Obstetrics and Gynaecology and 2 Reproductive Medicine, KK Women s and Children s Hospital, Singapore, Singapore Abstract Aim: Social oocyte freezing has gained increasing interest worldwide. We conducted a cross-sectional survey on 129 female medical students in Singapore to assess their mindset and attitudes toward fertility and social oocyte freezing. Methods: An anonymous online survey was conducted among female medical students in Singapore. The desired sample size was 100 participants. Their awareness of the existence of social oocyte freezing was first assessed. An information leaflet was provided subsequently, followed by a more detailed questionnaire. The questions focused on their awareness of age-related fertility decline and their intentions for social oocyte freezing if made available. Results: One hundred and twenty-nine female students participated in the electronic survey, of whom 36.4% had heard of social oocyte freezing. Of these, 70% had personally considered taking up this option. However, after reading the information leaflet, only 48.9% would still consider this option. Of the total, 89.9% considered themselves too old for pregnancy after the age of 35 years, 37.2% would delay family planning for their career, 45.7% would consider social oocyte freezing to postpone family planning for their career, 46.5% would consider oocyte freezing if they had no suitable partners yet, 50.4% may consider freezing their eggs after the age of 30 years and 71.3% may be more amenable to oocyte freezing if government subsidy is available. Conclusion: We hypothesize that social oocyte freezing may be a viable option for single young women who wish to delay child-bearing for reproductive insurance, so long as this is done with appropriate informed consent with non-directive counseling. Key words: medical students, reproductive insurance, social oocyte freezing, survey. Introduction Age is a crucial factor in infertility, and reproductive aging is an important social and medical phenomenon. There is an increasing trend for young women to delay their marriage and child-bearing plans in Singapore. This has contributed to the falling local fertility rates. According to the Singapore Department of Statistics, the median age of first marriage for brides rose from 23.6 years in 1980 to 28.0 years in With later marriage, the median age of citizen mothers rose from 28.7 years in 2001 to 29.8 years in Of note, there is a greater proportion of ever-married women in their 30s remaining childless. 2 A study by Singh et al. in 1988 looked at the fertility trends in Singapore, and attributed the drop in fertility rate to trends mainly toward higher socioeconomic class such as increasing female labor force participation, a break-up of the extended Received: August Accepted: November Reprint request to: Dr Shu Qi Tan, Medical Officer, Department of Obstetrics and Gynaecology, KK Women s and Children s Hospital, 100 Bukit Timah Road, Singapore shuqitan@gmail.com 2014 The Authors 1345

2 S. Q. Tan et al. family system, a rise in the age of first marriage, and more affluent and educated Singaporeans. 3 Older women more commonly experience subfertility by the time they are ready to become pregnant. Pregnancy rates decrease exponentially after a maternal age of 37 years, and enter an accelerated decline from age years. 4 As women start to become aware of the agerelated decline in fertility, interest in the emerging technologies of fertility preservation has grown. Although oocyte and ovarian tissue cryopreservation are commonly considered in women undergoing sterilizing treatment (e.g. chemotherapy, radiation therapy, ovarian resection), social oocyte freezing for women of advancing reproductive age remains controversial. Our study aims to look at the opinion of female medical students on social oocyte freezing to find out its role in our changing society. Methods The study was targeted at female medical students studying at our local universities (i.e. Yong Loo Lin School of Medicine and Duke-NUS Graduate Medical School). This group of participants was chosen as social oocyte freezing is still an emerging new medical development, and we hypothesize its awareness is higher among this medically inclined group. An online survey via the Google Docs platform was made available to all female medical students over a period of 1 month. The desired sample size was 100, as the primary objective of this study was to have a preliminary assessment of the opinions of medical students on social oocyte freezing. No incentives were given for completion of the survey, and the purpose of the survey was clearly explained to the participants prior to their online participation. The participants identities were anonymous, and informed consent was assumed upon submission of the survey forms. The results were subsequently analyzed. This study was reviewed and granted ethical approval by the SingHealth Centralized Institutional Review Board prior to its commencement. Results The online survey was made available over a period of 1 month in September 2012 to all female medical students studying in our local universities. One hundred and twenty-nine participants took part in the survey. Their awareness of the existence of social oocyte freezing was first assessed. An information leaflet was provided subsequently, followed by a more detailed questionnaire. The questions focused on their awareness of age-related fertility decline and their intentions for social oocyte freezing if made available. A copy of the sample information leaflet and questionnaire are attached in the Appendix for reference. The participants age ranged years old, with a mean age of 23.1 years. The characteristics of the participants are summarized in Table 1. Most of the participants (see Table 2) planned to have their first child between the age of 26 and 30 years, which corresponds to the median age of Singaporean citizen mothers at first birth (29.8 years in 2011). 2 On initial assessment, 36.4% (47 students) had heard of social oocyte freezing. Amongst this aware group, 70% (33 students) would personally consider taking up this option before reading the information leaflet. However, only 48.9% (23 students) of these still considered social oocyte freezing after reading the information leaflet (see Fig. 1). All the respondents were asked a second time if they would opt for social oocyte freezing after the initial assessment. Of the 129 respondents, 26.4% answered yes, 19.4% answered no, and 54.3% answered I do not know. Table 1 Characteristics of survey participants n % Age, years < > Race Chinese Malay Indian Other Religion Buddhist Catholic Christian Muslim Hinduism Other Table 2 At what age do you plan to have your first child? Age, years n (%) (0.8) (64.3) (32.6) (0.8) >40 2 (1.6) The Authors

3 Social oocyte freezing Table 3 Reasons for considering oocyte freezing Will you consider oocyte freezing Yes No Total (a) if you have no suitable partner yet? 60 (46.5%) 69 (53.5%) 129 (100%) (b) to focus on career and postpone family planning? 59 (45.7%) 70 (54.3%) 129 (100%) Table 4 Subanalysis of reasons for considering oocyte freezing To focus on career and postpone family building If no suitable partner Yes No Yes 40 (31.0%) 19 (14.7%) No 20 (15.5%) 50 (38.8%) Table 5 Timing of oocyte freezing Figure 1 Awareness of social oocyte freezing and uptake. What age will you freeze n % your oocytes? years years years years >40 years Total On assessment of timing for pregnancy and relation to career, 69.0% of the respondents considered themselves too old for pregnancy after the age of 35 years, and 37.2% of the respondents would delay family building for their career. The reasons for considering social oocyte freezing were explored (see Table 3), with 45.7% willing to consider social oocyte freezing to postpone family planning for their career and 46.5% of respondents willing to consider oocyte freezing if they had no suitable partners yet. Although 31.0% of the respondents would consider social oocyte freezing for both reasons, 14.7% would only consider this option to delay family building for career reasons, while 15.5% would consider this option solely if they had no available partner (see Table 4). The timing of uptake of social oocyte freezing was discussed. Most respondents (50.4%) felt that they may consider freezing their eggs after the age of 30 years (see Table 5) and 30% of the students felt that oocyte freezing should be made available to women up to the age of 45 years. With regards to cost of oocyte freezing, 34.1% felt that payment for this elective procedure should be entirely borne by the patient (see Fig. 2). However, should government subsidy be made available, 71.3% (92 students) of the respondents may be more amenable to oocyte freezing. Discussion Our survey revealed some important points about social oocyte freezing. First, only 36.4% of our medical students are aware of the availability of this procedure. Given the assumption that medical students should have better knowledge of the current new medical developments, this highlights the need to create greater public awareness before this procedure can be offered to the general public. Accurate information on the details regarding social oocyte freezing also should be made available to the general public for it to be a viable option. Our study noted that of the students who are aware of the procedure, there was a sharp decline in the percentage (from 70% to 48.9%) who would personally consider taking up social oocyte freezing after reading the information leaflet, which discussed the success rates of oocyte freezing, the procedure for oocyte retrieval, as well as the cost of the procedure. The importance of providing 2014 The Authors 1347

4 S. Q. Tan et al. Figure 2 Who should pay for social oocyte freezing? adequate information to the patients who consider social oocyte freezing is paramount given the many implications involved: medical, social and emotional. Medical implications need to be spelt out for proper informed consent for the procedure, as this may sway decisions made by the patients. The timeframe for social oocyte freezing is also crucial. Of our respondents, 50.4% felt that they may consider oocyte freezing after the age of 30 years. Reasons cited include delaying family planning for career reasons, and lack of a suitable partner. Such reasons are not limited to the medical field. Many other professionals may face a similar dilemma with increasing age. The natural history of fecundity as well as success rates with older cryopreservation particularly should be highlighted to secure the best age timeframe for social freezers. Our survey group targeted a young population mainly in the age range of years.at the time of study, they may not have not felt the pressure of their ticking biological clock. However, it is important to raise awareness among young women. The average reported age of non-medical patients freezing their oocytes is 38 years. 5 8 Research has shown that freezing above 43 years is not recommended with pregnancy rates per cycle of 2% and lower. 9 In our survey, 30% of our medical students felt that it should be made available to women up to the age of 45 years. This suggests that there is a big gap that needs to be filled to improve the public s knowledge on the truth about social oocyte freezing. Women should be adequately advised on the improved embryo quality and reduced prevalence of aneuploid oocytes with younger age. One common argument raised against social oocyte freezing is the probable resultant delay in age of marriage and childbirth for women. This is a notable concern, as our survey reflects that nearly half of our respondents would consider oocyte freezing to focus on their career. However, it is important to note that one of the other important reasons to consider oocyte freezing is the lack of a suitable partner. The various reasons for uptake of social oocyte freezing should be considered, and explored by clinicians to facilitate effective counseling for this elective procedure. Overall, only 26.4% of our surveyed population would eventually opt for social oocyte freezing, while 54.3% were unsure. This trend is also reflected in a similar online survey performed by the Bioethics Legal group for Reproductive Issues in Singapore (BELRIS) 10 to evaluate the position of Singaporean women on oocyte freezing in Singapore. In BELRIS s survey, only 22% of respondents stated that they are likely to opt for elective oocyte freezing, and 47% were unsure. Interestingly, the Singaporean attitudes toward oocyte freezing reflect a stark contrast to results shown in a Belgium survey conducted by Stoop et al. 11 The Belgium group had only 3.1% of the respondents who would consider freezing their oocytes, while 45.1% were unsure and 51.8% answered no. This difference is not attributed to knowledge about social oocyte freezing. Stoop et al. 11 reported that women who consider oocyte freezing did not appear to have better awareness of reproductive aging. Possible explanations for this difference could be cultural and societal mindset. Stoop et al. 11 suggested that their group of potential oocyte freezers had a greater desire for more children, as this option would possibly prolong their reproductive years. This may not be relevant to our population, where a local study found a statistically significant trend for the younger population to have no intention for children. 12 The desire for reproductive insurance seems to be the main contributing factor in our Singaporean population, where the most selected reason by potential freezers in the BELRIS 10 study was to have a safety net in case of future reproductive problems. Our results reflect a similar trend for need for reproductive insurance, where most respondents may consider oocyte freezing after the age of 30 years should they remain childless, keeping in mind that the majority of our respondents planned to have their first child between the ages 26 of 30 years The Authors

5 Social oocyte freezing Given that reproductive insurance is a major reason for local women to favor social oocyte freezing, it is paramount that the successful clinical pregnancy rates are dutifully presented. It must be emphasized that oocyte freezing may retain the chance of being a genetic parent. However, there is no guarantee that a live birth will result. Such information must be properly translated to the public prior to uptake of the procedure to prevent misconceptions. Nevertheless, this option of reproductive insurance has a huge price tag. Social oocyte freezing is currently prohibited in Singapore. By extrapolating the current government policies to funding of this elective procedure, the cost is still quite hefty. Nearly one third of our respondents (34.1%) felt that payment for this elective procedure should be paid entirely by the patients. However, the uptake rate may increase to 71.3% should government subsidy be made applicable to this procedure. This is important for the government making policies as the trend to postpone childbearing plans for the sake of a career has increased in the local setting over recent years. Given the expensive nature of this elective procedure, working out the payment issues for this particular group of competitive working women may influence their decision for social oocyte freezing. Our survey targeted a focused competitive population which is more likely to uptake social oocyte freezing for career reasons, and we took advantage of their medical knowledge to evaluate the role of oocyte freezing in our Singaporean society. It has highlighted a few key points. First, public awareness and knowledge about social oocyte freezing is inadequate. With appropriate informed consent and non-directive counseling, social oocyte freezing may be a viable option for women who wish to obtain this reproductive insurance. In addition, women are likely to be more amendable to take up the procedure if government funding is made available. This may be useful for policy makers to consider when implementing government policies and allocation of budget. Acknowledgments We would like to thank our female medical students at Yong Loo Lin School of Medicine and Duke-NUS Graduate Medical School for their kind participation in the survey. We would also like to thank Dr Ku Chee Wai for his kind assistance with setting up the online survey via the Google Docs platform. Disclosure None References 1. Singapore Department of Statistics. Demographic Indicators, Singapore Department of Statistic. Population in Brief Singh K, Viegas O, Ratnam SS. Fertility trends in Singapore. J Biosoc Sci 1988; 20: Committee on Gynecologic Practice of American College of Obstetricians and Gynecologists; Practice Committee of American Society for Reproductive Medicine. Age-related fertility decline: A committee opinion. Fertil Steril 2008; 90 (5 Suppl): S154 S Gold E, Copperman K, Witkin G, Jones C, Capperman AB. P-187: A motivational assessment of women undergoing elective egg freezing for fertility preservation. Fertil Steril 2006; 86: S Klein J, Howard M, Grunfeld L, Mukherjee T, Sandler B, Copperman AB. P-486: Preliminary experience of an oocyte cryopreservation of an oocyte cryopreservation program: Are patients presenting too late? Fertil Steril 2006; 86: S Sage CFF, Kolb BM, Treiser SL, Silverberg KM, Barrit J, Copperman AB. Oocyte cryopreservation in women seeking elective fertility preservation a multicenter analysis. Obstet Gynecol 2008; 111: 20S. 8. Nekkebroeck J, Stoop D, Devroey P. O-036 a preliminary profile of women opting for oocyte crypreservation for nonmedical reasons. Hum Reprod 2010; 25: 1l5 1l6. 9. Hourvitz A, Machtinger R, Maman E et al. Assisted reproduction in women over 40 years of age: How old is too old?, Reprod Biomed Online 2009; 19: BELRIS. Report on Survey Conducted to Evaluate the Position of Elective Oocyte Freezing in Singapore. Newsletter [Cited 2013.] Available from URL: -content/uploads/2013/06/belris-newsletter_q2 _2013.pdf 11. Stoop D, Nekkebroeck J, Devroey P. A survey on the intentions and attitudes toward oocyte cryopreservation for medical reasons among women of reproductive age. Hum Reprod 2011; 26: Tan TC, Tan SQ, Wei X. Cross-sectional pregnancy survey on fertility trends and pregnancy knowledge in Singapore. J Obstet Gynaecol Res 2011; 37: Appendix I Social oocytes freezing: to do or not to do? 1. What is your race? Chinese Malay Indian Others (please specify: ) 2. What is your age? 3. What is your religion? Buddhist Muslim Christian Hinduism 2014 The Authors 1349

6 S. Q. Tan et al. Catholic Non-religious Others (pls specify: ) 4. Do you plan to have children? 5. At what age do you plan to have your first child? >40 6. Will you delay family planning for your career? 7. If so, are you worried about impaired fertility due to advanced age? 8. When do you consider yourself too old to get pregnant? >21 >26 >31 >35 >40 9. Would you consider freezing your oocytes at some point in time? I do not know 10. At what age would you consider oocyte freezing? > Would you consider oocyte freezing if you have no suitable partner yet? 12. Would you consider oocyte freezing to focus on your career and postpone family planning? 13. Who should pay for the oocytes freezing? Self Cash Medisave Government-Subsidy 14. If there is government subsidy available for oocyte freezing, would you be more amendable to freezing your eggs? 15. What do you think is the upper age limit for pregnancy? i.e. when is it not acceptable for a woman to get pregnant? >45 >50 >55 > Do you think social oocytes freezing should be offered to woman in all ages? If no, which age group should egg freezing be made available to? Appendix II PARTICIPANT INFORMATION SHEET Protocol Title: Social Oocyte freezing: To do or not to do? A survey amongst Singapore female medical students. Principal Investigator(s): Dr Tan Wei Keat, Medical Officer, KK Women s and Children s Hospital Dr Tan Shu Qi, Medical Officer, KK Women s and Children s Hospital PURPOSE OF THE RESEARCH STUDY You are being invited to participate in a cross sectional study to find out the role of social oocyte freezing in our local population. There is increasing trend for young women to delay their childbearing plans till later in their reproductive years. This is largely attributed to postgraduate academic pursuit and higher levels of professional achievement. Studies have shown a trend for young women to delay their child bearing age. However, the ability to conceive is strongly influenced by a woman s age. Older women more commonly experience subfertility by the time they are ready to become pregnant. As many women started to become aware of the age-related decline in fertility, interest in the emerging technologies of fertility preservation has grown. Our study aims to look at societal opinions on social oocyte freezing to halt the effects of time on reproductive function The Authors

7 Social oocyte freezing NATURAL FECUNDITY Fecundity refers to the ability to reproduce. The fertility of a woman is mainly influenced by her age. The progressive loss of oocytes that occurs from fetal life until menopause is one of the defining features of the age-related decline in female fertility. The oocyte pool peaks at birth. Subsequently, progressive atresia occurs, and happens at an accelerated rate after the age of 37 in normal women till menopause. As the number of oocytes declines over time, the quality of oocytes also declines, resulting in an increased prevalence of aneuploid oocytes due to dysfunctions of the meiotic spindle. Studies have consistently demonstrated a decline in pregnancy rates with advancing maternal age, with higher rates of miscarriage among older women. These relationships are best illustrated by outcome data from clinics performing in vitro fertilization. With age-relate decreasing fecundity coupled with the delay in childbearing age in modern society, Leridon et al. 1 have shown that this has resulted in an up to 73% increase in need for fertility treatments. IVF PREGNANCY RATES The most important factor by far when assessing pregnancy outcomes in IVF cycles is female age. More oocytes can be harvested with improved live birth rates in the younger patients. Results at our KK IVF centre based on 2008 data are summarized as shown. < >40 Mean no of oocytes collected Mean no of embryos formed Live Birth Rates (fresh cycle) 43.4% 43.5% 26.3% 9.0% INFORMATION ABOUT OOCYTE FREEZING The first successful pregnancy from oocyte cryopreservation was reported in However, oocyte freezing is still regarded as a relatively experimental procedure by most major regulatory bodies in the United States and Europe, particularly for social indications. This is due to concerns about the procedure s success rates and safety for future offspring. However, with improving techniques like vitrification for oocyte freezing, there is an increasing trend for social oocyte freezing, especially in ladies who are postponing childbirth to a later age. For women who do not have a participating male partner and are not interested in using donor sperm, oocyte cryopreservation is generally the preferred option until a suitable partner is found. OOCYTE FREEZING Traditionally, oocytes are frozen via slow freeze method, but with poor outcomes. Vitrification is a relatively new approach to oocyte freezing. The first reported live birth from vitrified human oocytes was in It is based upon the principle that metabolically active cells can be cooled so rapidly that ice does not have time to form. Successful use of vitrification procedures has been reported in animal models, and the number of human live births resulting from vitrification of oocytes is encouraging. Several case series showing promising results have been published. A meta-analysis including five reports on vitrification estimated fertilization rates of 74 percent (637/859), clinical pregnancy rates per transfer of 45.5 percent (61/134), and live birth rate per transfer of 36.6 percent (49/134). A study comparing fresh and vitrified oocytes shows comparable embryo quality, pregnancy rates and implantation potential for both arms. 2 The data is summarized the table below The Authors 1351

8 S. Q. Tan et al. Fresh Frozen (Vitrified) P value Oocyte survival rates (%) NA 91.4% NA Fertilization rate (%) No of resultant embryos 5 ± ± Pregnancy rate per embryo transfer (%) Live birth rate (%) 41.5% 47.2% 0.61 PROCEDURE Potential candidates will generally undergo baseline ovarian reserve testing prior to initiating treatment. The processes of embryo and oocyte cryopreservation are identical to that of in vitro fertilization up until the time of the oocyte retrieval. Controlled ovarian hyperstimulation with daily injectable gonadotropins is initiated in the early follicular phase or after an interval on the birth control pills, and continues for approximately 10 to 14 days to achieve multiple peri-ovulatory follicles. The oocyte retrieval is performed via needle aspiration utilizing transvaginal ultrasound guidance, typically under conscious sedation. Mature oocytes retrieved are frozen on the day of the oocyte retrieval. For sufficient oocyte collection (usually about 20 oocytes), 3 cycles of oocyte stimulation and retrival are usually required. COST The cost of embryo and oocyte cryopreservation procedures is comparable to that of in vitro fertilization. A single cycle including monitoring visits, surgical, anaesthesia and embryology is approximately $8000. For 3 cycles, the cost is estimated at $ Annual storage fees are approximately $400 per year. LONG TERM FOLLOW UP OF CHILDREN There is limited data on the long term follow up of children for oocyte vitrification techniques. In the largest study, Chian et al. 3 (2008) reported data on 200 children. The mean birth weight was 2920 grams for singletons and 2231 grams for multiples. The low birth weight rate among singletons was 18% and among multiples 80%. The premature delivery rate was 26% for singletons and 71% for multiple pregnancies. The incidence of congenital malformations was 2.5%. A review by Wennerholm et al. 4 revealed a total of 221 successful infants born via this technique, but there is no long term child follow up data for cryopreservation techniques as of now. CONCLUSION Vitrification of oocytes promises to be an effective method of fertility preservation for women. We would like to gauge the opinion of future professional women, such as yourself, on fertility preservation with oocyte cryopreservation. Thank you for taking the time to participate in our survey. 1 Leridon H, Slama R, The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand on assisted reproduction technology, Human Repro, 2008; 23: Trokoudes KM, Pavlides C, Zhang X, Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program, Fert Stert, 2011; 95: Chian RC, Huang JY, Gilbert L et al., Obstetric outcomes following vitrification of in-vitro and in vivo matured oocytes, Fertil Steril, Wennerholm UB, Soderstrom-Anttila V, Bergh C et al., Children born after cryopreservation of embryos or ooctes: a systematic review of outcome data, Human Repro, 2009; 24: The Authors

The Age of ART cont. The ART of Donation

The Age of ART cont. The ART of Donation The Age of ART cont. The ART of Donation Review and scope Growing trend to delay reproduction Decline of female fecundity with age Lack of public awareness Can ART compensate for the natural decline of

More information

The status of oocyte cryopreservation in the United States

The status of oocyte cryopreservation in the United States The status of oocyte cryopreservation in the United States Briana Rudick, M.D., Neisha Opper, M.P.H., Richard Paulson, M.D., Kristin Bendikson, M.D., and Karine Chung, M.D., M.S.C.E. Department of Obstetrics

More information

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida

FERTILITY PRESERVATION. Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida FERTILITY PRESERVATION Juergen Eisermann, M.D., F.A.C.O.G South Florida Institute for Reproductive Medicine South Miami Florida 1 2 3 4 Oocyte Cryopreservation Experimental option Offer to single cancer

More information

Fertility, Egg Freezing, and You. If you have questions, we can help you get answers.

Fertility, Egg Freezing, and You. If you have questions, we can help you get answers. Fertility, Egg Freezing, and You If you have questions, we can help you get answers. Let s talk about fertility If you re thinking about having a baby someday but aren t ready now, you should learn all

More information

Fertility care for women diagnosed with cancer

Fertility care for women diagnosed with cancer Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment

More information

Counseling for Potential Clients of RT Services

Counseling for Potential Clients of RT Services Assisted Reproductive Technology Unit Department of Obstetrics and Gynaecology The Chinese University of Hong Kong The Prince of Wales Hospital Counseling for Potential Clients of RT Services Husband s

More information

Egg Freezing for. Your Future. Specialists in Reproductive Medicine & Surgery, P.A.

Egg Freezing for. Your Future. Specialists in Reproductive Medicine & Surgery, P.A. Egg Freezing for Your Future Specialists in Reproductive Medicine & Surgery, P.A. www.dreamababy.com Egg freezing can be a game changer for women 40 years of age and younger. It has tremendous potential

More information

WHAT IS A PATIENT CARE ADVOCATE?

WHAT IS A PATIENT CARE ADVOCATE? WHAT IS A PATIENT CARE ADVOCATE? Fertility treatments can be overwhelming. As a member, you have unlimited access to a dedicated Patient Care Advocate (PCA), who acts as your expert resource for discussing

More information

EGG BANKS program at clinique ovo

EGG BANKS program at clinique ovo EGG BANKS program at clinique ovo HISTORY The first pregnancy resulting from egg donation in an IVF cycle was in 1983 Egg donation plays an important role in assisted reproductive technologies since it

More information

CONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS

CONSENT TO CRYOPRESERVATION AND STORAGE OF HUMAN EMBRYOS 1. Name(s) of Party/Parties A. Party/parties requesting freezing of embryos a. Couple We, and of County, City of in the state of are (married or domestic partners) and are over the age of twenty-one years.

More information

Women s consent to the use and storage of eggs or embryos for surrogacy

Women s consent to the use and storage of eggs or embryos for surrogacy Women s consent to the use and storage of eggs or embryos for surrogacy HFEA WSG form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition Patient Name (please print) Patient DOB (MM/DD/YYYY) Patient eivf number Partner

More information

Female Patient Name: Social Security # Male Patient Name: Social Security #

Female Patient Name: Social Security # Male Patient Name: Social Security # Female Patient Name: Social Security # Male Patient Name: Social Security # THE CENTER FOR HUMAN REPRODUCTION (CHR) ILLINOIS/NEW YORK CITY * ASSISTED REPRODUCTIVE TECHNOLOGIES PROGRAM (A.R.T.) CRYOPRESERVATION

More information

Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Main Line Fertility Center. Egg Freezing. Informed Consent Form

Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Main Line Fertility Center. Egg Freezing. Informed Consent Form Page 1 of 5 Egg Freezing Informed Consent Form version 2018 Egg Freezing Informed Consent Form Embryos and sperm have been frozen and thawed with good results for many years. Egg (oocyte) freezing is a

More information

Clinical Policy Committee

Clinical Policy Committee Northern, Eastern and Western Devon Clinical Commissioning Group South Devon and Torbay Clinical Commissioning Group Clinical Policy Committee Commissioning policy: Assisted Conception Fertility treatments

More information

Clinical Policy Committee

Clinical Policy Committee Clinical Policy Committee Commissioning policy: Assisted Conception Fertility assessment and investigations are commissioned where: A woman is of reproductive age and has not conceived after one (1) year

More information

How to Select an Egg Donor

How to Select an Egg Donor How to Select an Egg Donor How to Select an Egg Donor Egg donation entails the fertilization of eggs of a young woman and transfer of the resulting embryo or embryos into the intended mother uterus. In

More information

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life?

How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? How effective is egg freezing as a preventative treatment for young women in securing their ability to reproduce later in life? Vitaly A. Kushnir MD Center for Human Reproduction New York City Milestones

More information

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI)

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) HFEA MT form (Gender-neutral version) Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI) About this form This form is produced by the Human Fertilisation and Embryology

More information

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ CHAPTER 8: Donation Although there has been a reduction in the use of donor sperm because of ICSI and the impact of the removal of anonymity in some countries (1), sperm donation is still used and has

More information

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification

Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Risk of congenital anomalies in children born after frozen embryo transfer with and without vitrification Aila Tiitinen Professor, reproductive medicine Head of IVF unit Helsinki University The outline

More information

The facts about egg freezing

The facts about egg freezing The facts about egg freezing 1800 111 483 qfg.com.au Who might benefit from egg freezing? Age-related infertility in women is one of the most common issues presented to fertility specialists each day when

More information

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16

St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 St Helens CCG NHS Funded Treatment for Subfertility Policy 2015/16 1 Standard Operating Procedure St Helens CCG NHS Funded Treatment for Sub Fertility Policy Version 1 Implementation Date May 2015 Review

More information

Men s consent to the use and storage of sperm or embryos for surrogacy

Men s consent to the use and storage of sperm or embryos for surrogacy HFEA MSG form Men s consent to the use and storage of sperm or embryos for surrogacy About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent

More information

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO

More information

RA Anderson, MC Davies, SA Lavery, on behalf of the Royal College of Obstetricians and Gynaecologists

RA Anderson, MC Davies, SA Lavery, on behalf of the Royal College of Obstetricians and Gynaecologists 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 Scientific Impact Paper No. XX Peer Review Draft January

More information

CONSENT FOR ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition

CONSENT FOR ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition CONSENT F ASSISTED REPRODUCTION In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, Embryo Freezing and Disposition Please read the following consent carefully. If you do not understand

More information

Women s consent to treatment and storage form (IVF and ICSI)

Women s consent to treatment and storage form (IVF and ICSI) Women s consent to treatment and storage form (IVF and ICSI) HFEA WT form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information

your guide to egg freezing Clinical excellence & bespoke fertility care

your guide to egg freezing Clinical excellence & bespoke fertility care your guide to egg freezing Clinical excellence & bespoke fertility care Egg freezing The CRGH uses a new freezing technique called vitrification. In order to freeze an egg, water must first be removed

More information

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility

More information

Your consent to the storage of your eggs or sperm

Your consent to the storage of your eggs or sperm Your consent to the storage of your eggs or sperm HFEA GS form About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility

More information

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE

ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE ASSISTED CONCEPTION NHS FUNDED TREATMENT FOR SUBFERTILITY ELIGIBILITY CRITERIA & POLICY GUIDANCE Version 1.0 Page 1 of 11 MARCH 2014 POLICY DOCUMENT VERSION CONTROL CERTIFICATE TITLE Title: Assisted Conception

More information

Egg freezing. what you need to know

Egg freezing. what you need to know Egg freezing what you need to know With over 30 years of experience in IVF treatment, we offer clinical excellence at an affordable cost in an environment that understands and caters specifically for women

More information

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation

Leicester City, East Leicestershire and Rutland & West Leicestershire Collaborative Commissioning Policy Gamete/Embryo cryopreservation Leicester City Clinical Commissioning Group West Leicestershire Clinical Commissioning Group East Leicestershire and Rutland Clinical Commissioning Group Leicester City, East Leicestershire and Rutland

More information

Recommended Interim Policy Statement 150: Assisted Conception Services

Recommended Interim Policy Statement 150: Assisted Conception Services Southampton City Clinical Commissioning Group (CCG) took on commissioning responsibility for Assisted Conception Services from 1 April 2013 for its population and agreed to adopt the interim policy recommendations

More information

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY CONTENTS Page 1. INTRODUCTION 2 2. GENERAL PRINCIPLES 2 3. DEFINITION OF SUBFERTILITY AND TIMING OF ACCESS TO TREATMENT 3 4. DEFINITION

More information

Produce Eggs. Fertility Preservation for Trans People who. LGBTQ Reproductive Options

Produce Eggs. Fertility Preservation for Trans People who. LGBTQ Reproductive Options for Trans People who Produce Eggs LGBTQ Reproductive Options Many trans people are interested in being parents and want to know their options. While many trans people may conceive on their own, this info

More information

Approved January Waltham Forest CCG Fertility policy

Approved January Waltham Forest CCG Fertility policy Approved January 2015 Waltham Forest CCG Fertility policy Contents 1 Introduction 1 2 Individual Funding Requests 1 2.1 Eligibility criteria 1 2.2 Number of cycles funded 2 2.3 Treatment Pathway 3 Page

More information

Adoption and Foster Care

Adoption and Foster Care GLOSSARY Family building via Adoption and Foster Care October 2018 www.familyequality.org/resources A Anonymous Donor: A person who donated sperm or eggs with the intention of never meeting resulting children.

More information

Top 10 questions in fertility

Top 10 questions in fertility Top 10 questions in fertility Mr Rehan Salim MD MRCOG Head of Reproductive Medicine Consultant Gynaecologist & Subspecialist in Reproductive Medicine Imperial College NHS Trust Learning objectives Patient

More information

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception 1 Introduction Blackpool CCG Policies for the Commissioning of Healthcare Assisted Conception 1.1 This policy describes circumstances in which NHS Blackpool Clinical Commissioning Group (CCG) will fund

More information

Information for Recipient of Donor Oocytes

Information for Recipient of Donor Oocytes Introduction Thank you for expressing an interest as an oocyte recipient in our oocyte donation program at the Family Fertility Center. Our successful program was established since 1994 and is directed

More information

Fertility preservation for women wishing to freeze egg/ embryo for fertility preservation

Fertility preservation for women wishing to freeze egg/ embryo for fertility preservation Fertility preservation for women wishing to freeze egg/ embryo for fertility preservation The aim of this leaflet is to help answer some of the questions you may have about fertility preservation. It explains

More information

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction

Trends in Egg Donation. Vitaly A. Kushnir MD Center for Human Reproduction Trends in Egg Donation Vitaly A. Kushnir MD Center for Human Reproduction Disclosures No relevant financial relationships to disclose CHR views the commercial trade in human oocytes with considerable ethical

More information

Recent Developments in Infertility Treatment

Recent Developments in Infertility Treatment Recent Developments in Infertility Treatment John T. Queenan Jr., MD Professor, Dept. Of Ob/Gyn University of Rochester Medical Center Rochester, NY Disclosures I don t have financial interest or other

More information

Access to IVF. Help us decide Discussion paper. South Central Specialised Commissioning Group C - 1

Access to IVF. Help us decide Discussion paper. South Central Specialised Commissioning Group C - 1 Access to IVF Help us decide Discussion paper South Central Specialised Commissioning Group 1 C - 1 Access to IVF treatment Contents 1. Background 3 2. Developing a single policy for NHS South Central..4

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1.

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. *40675* 40675 MR-838 (9-2017) WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IN VITRO FERTILIZATION USING A GESTATIONAL CARRIER (PATIENT/INTENDED PARENTS) 1. I, and (Print Patient s name) (Print

More information

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent

Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent Preimplantation Genetic Testing (PGT) Fresh and Frozen Embryos Process, Risk, and Consent PGT analysis is offered to patients that seek to identify a chromosomal abnormality in their embryos prior to initiating

More information

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS. I and

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS. I and *40668* 40668 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR THAWING AND TRANSFER OF CRYOPRESERVED EMBRYOS FOR inpatients: affix patient label OR I and (Print Patient s name) (Print Partner

More information

Therapeutic Sperm Banking

Therapeutic Sperm Banking Therapeutic Sperm Banking An Option for Preserving Male Fertility Andrology Laboratory and Reproductive Tissue Bank Information For Patients Men undergoing cancer treatment, including certain types of

More information

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019

JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 JAWDA Quarterly & Yearly Guidelines for Assisted Reproductive Technology Treatment (ART) Providers January 2019 Page 1 Table of Contents Executive Summary... 3 About this Guidance... 4 Glossary:... 5 ART

More information

Policy statement. Commissioning of Fertility treatments

Policy statement. Commissioning of Fertility treatments Policy statement Commissioning of Fertility treatments NB: The policy relating to commissioning of fertility treatments is unchanged from the version approved by the CCG in March 2017. The clinical thresholds

More information

T39: Fertility Policy Checklist

T39: Fertility Policy Checklist Patient Name: Address: Date of Birth: NHS Number: Consultant/Service to whom referral will be made: Institution Lifestyle Information Latest BMI: Latest BP: Smoking Status: Has the patient been referred

More information

Egg Freezing. Information for Patients and Partners. Date of Issue:28/08/15 Doc 327 Issue 08 1 of 11 Approved by Jane Blower

Egg Freezing. Information for Patients and Partners. Date of Issue:28/08/15 Doc 327 Issue 08 1 of 11 Approved by Jane Blower Egg Freezing Information for Patients and Partners Date of Issue:28/08/15 Doc 327 Issue 08 1 of 11 What is this service and who is it for? This treatment is for two groups of patients. You may be about

More information

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

Planning for Parenthood After a Cancer Diagnosis

Planning for Parenthood After a Cancer Diagnosis Cancer and Fertility Planning for Parenthood After a Cancer Diagnosis If you or someone you love is facing cancer, preserving fertility may be the last thing on your mind. But if you re a woman of childbearing

More information

Fertility Policy. December Introduction

Fertility Policy. December Introduction Fertility Policy December 2015 Introduction Camden Clinical Commissioning Group (CCG) is responsible for commissioning a range of health services including hospital, mental health and community services

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2. COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.3 2017 Agreed at Cannock Chase CCG Signature: Designation: Chair of

More information

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Islington CCG Fertility Policy First approved: 29 January 2015 Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018) Introduction Islington CCG

More information

GAMETE STORAGE. Reviewing body Review date Version no

GAMETE STORAGE. Reviewing body Review date Version no GAMETE STORAGE Document History Date of publication July 2016 Version Number: V1 Review date July 2018 Consultation Consultee Which group Public health INPUT Derbyshire Affiliated Commissioning Committee

More information

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017 This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator of fertility treatment and human embryo research. For more information about us, visit www.hfea.gov.uk.

More information

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES Version number V2.3 Responsible individual Author(s) Barry Weaver Trish

More information

Regardless of your reasons, think about your future.

Regardless of your reasons, think about your future. Regardless of your reasons, think about your future. Genea Horizon is an egg freezing clinic in the heart of Sydney s CBD. The first of its kind and drawing on over 30 years of experience in IVF treatment,

More information

Consent to Shipment of Frozen Embryos to and Short Term Storage of Frozen Embryos at the Family Fertility Center

Consent to Shipment of Frozen Embryos to and Short Term Storage of Frozen Embryos at the Family Fertility Center 1. Background On or about and requested clinic and treating physician) at (date), name(s) of parties underwent IVF treatment) (name of (address of clinic) to perform in vitro fertilization using: a. Oocyte

More information

FORTY IS THE NEW THIRTY, RIGHT?

FORTY IS THE NEW THIRTY, RIGHT? FORTY IS THE NEW THIRTY, RIGHT? by MARGO R. FLUKER, MD, FRCSC Co-director, Genesis Fertility Centre It s a sign of our times: fit, healthy, fabulous-looking women in their forties and even in their fifties.

More information

Patient Information: Patient Name: Date of Birth:

Patient Information: Patient Name: Date of Birth: Weill Cornell Medicine Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine Informed Consent for Oocyte (Egg) Cryopreservation Patient Information: Part 1: I have requested to be treated

More information

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER

WOMEN & INFANTS HOSPITAL Providence, RI CONSENT FOR IVF WITH EMBRYO TRANSFER *40639* 40639 WOMEN & INFANTS HOSPITAL Providence, RI 02905 CONSENT FOR IVF WITH EMBRYO TRANSFER I have requested treatment by the physicians and (Print Patient s name) staff of the Women & Infants Fertility

More information

CONSENT FOR CRYOPRESERVATION OF EMBRYOS

CONSENT FOR CRYOPRESERVATION OF EMBRYOS CONSENT FOR CRYOPRESERVATION OF EMBRYOS We, (Female Partner) and (Partner, Spouse), as participants in the in vitro fertilization (IVF) program at the Reproductive fertility center (REPRODUCTIVE FERTILITY

More information

Possibilities Plan. Access to the care you need.

Possibilities Plan. Access to the care you need. Possibilities Plan If you do not have insurance or have insurance but lack coverage for infertility services and are concerned about the cost of infertility services, The Center for Advanced Reproductive

More information

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States.

10/16/2014. Adolescents (ages 10 19) and young adults (ages 20 24) together compose about 21% of the population of the United States. The purview of pediatrics includes the growth, development, and health of the child and therefore begins in the period before birth when conception is apparent. It continues through childhood and adolescence

More information

CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE

CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE INFERTILITY & IVF MEDICAL ASSOCIATES OF WESTERN NEW YORK CRYOPRESERVATION OF SEMEN FROM TESTICULAR TISSUE BUFFALOIVF.COM When you have scheduled your appointment with Dr Crickard or Dr Sullivan to sign

More information

INTRACYTOPLASMIC SPERM INJECTION

INTRACYTOPLASMIC SPERM INJECTION 1 Background... 2 2 Male Factor Infertility... 2 3 ICSI... 3 4 Surgical sperm aspiration... 4 5 What is the chance of success?... 6 6 What are the risks?... 7 M Rajkhowa, October 2004 Authorised by V Kay

More information

CONSENT In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition

CONSENT In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition CONSENT In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition Please Print PATIENT Name: Patient DOB: _/ _/ Patient eivf number: PARTNER Name

More information

Cancer Fertility. Fertility Options to Consider Before Treatment Begins & Parenthood Options After Cancer

Cancer Fertility. Fertility Options to Consider Before Treatment Begins & Parenthood Options After Cancer & Cancer Fertility Fertility Options to Consider Before Treatment Begins & Parenthood Options After Cancer If you or someone you care about is faced with a cancer diagnosis, preserving fertility may be

More information

Information For Egg Recipients

Information For Egg Recipients Egg Recipients Royal Devon and Exeter NHS Foundation Trust Information For Egg Recipients What is egg donation? Egg donation is a type of in-vitro fertilisation (IVF) treatment in which eggs are collected

More information

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM

THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner

More information

Consent for In Vitro Fertilization with Donor Oocyte: Donor - Patient/Husband

Consent for In Vitro Fertilization with Donor Oocyte: Donor - Patient/Husband with Donor Oocyte: Donor - Patient/Husband Name of Patient: Name of Partner: I, the Patient, and my husband (if applicable) named above, are each over the age of twenty-one (21) years. I am a healthy female

More information

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title GOVERNING BOARD Date of Meeting 21 January 2015 Agenda Item No 13 Title Assisted Conception (IVF): Review of access criteria Purpose of Paper The SHIP (Southampton, Hampshire, Isle of Wight and Portsmouth)

More information

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1 Puberty and Fertility Jennifer Badik*, MD Pediatric Endocrinology and Jessica Spencer*, MD, MSc Reproductive Endocrinology and Infertility Part One PUBERTY! *no conflicts of interest to report Every girl

More information

Virtual Mentor American Medical Association Journal of Ethics September 2007, Volume 9, Number 9:

Virtual Mentor American Medical Association Journal of Ethics September 2007, Volume 9, Number 9: Virtual Mentor American Medical Association Journal of Ethics September 2007, Volume 9, Number 9: 630-634. Policy Forum A Match Made in Heaven: Posthumous Fatherhood and Postmenopausal Motherhood Senait

More information

Couples Information Leaflet

Couples Information Leaflet Couples Information Leaflet This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 13/115/82) You are due to undergo in vitro fertilisation

More information

Unlimited IVF 100% refund if you don t have a baby

Unlimited IVF 100% refund if you don t have a baby Unlimited IVF 100% refund if you don t have a baby In partnership with Take the uncertainty out of IVF Undergoing IVF treatment can be a stressful time, both personally and financially. Access Fertility

More information

INTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen.

INTRODUCTION TABLE OF CONTENTS. If you want to become a parent after cancer, we would like to give you the information you need to make that happen. TABLE OF CONTENTS INTRODUCTION INTRODUCTION 1 MEN Fertility Risks 2 Fertility Preservation Options 3 Possible Fertility Outcomes 4 Parenthood After Cancer Options 5 Important Tips for Men 6 WOMEN Fertility

More information

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler

Committee Paper SCAAC(05/09)01. ICSI guidance. Hannah Darby and Rachel Fowler Committee Paper Committee: Scientific and Clinical Advances Advisory Committee Meeting Date: 12 May 2009 Agenda Item: 4 Paper Number: SCAAC(05/09)01 Paper Title: ICSI guidance Author: Hannah Darby and

More information

IN VITRO FERTILIZATION

IN VITRO FERTILIZATION FERTILITY AND STERILITY VOL. 76, NO. 1, JULY 2001 Copyright 2001 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION

More information

WHAT YOU DIDN T KNOW, BUT NEED TO

WHAT YOU DIDN T KNOW, BUT NEED TO WHAT YOU DIDN T KNOW, BUT NEED TO In 2016, 7 million people will try to conceive through natural pregnancy, but only 5 million will be successful 20% of women are born with low ovarian reserve 200,000

More information

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility NHS Birmingham and Solihull Clinical Commissioning Group NHS Sandwell and West Birmingham Clinical Commissioning Group DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation

More information

Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation

Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation Chapter 17 Oncofertility Consortium Consensus Statement: Guidelines for Ovarian Tissue Cryopreservation Leilah E. Backhus, MD, MS, Laxmi A. Kondapalli, MD, MS, R. Jeffrey Chang, MD, Christos Coutifaris,

More information

[p.1 of Form (8)] SAMP Consent to Designated Donation of Sperm. 1. I (name of donor) (hereinafter

[p.1 of Form (8)] SAMP Consent to Designated Donation of Sperm. 1. I (name of donor) (hereinafter [p.1 of Form (8)] SAMP Consent to Designated Donation of Sperm Part I DONOR S CONSENT 1. I (name of donor) (hereinafter (Surname, Given s) (ID No.) called the Donor ), DO HEREBY CONSENT to donating my

More information

Section III Consent Forms

Section III Consent Forms Section III Consent Forms Please read the consents prior to your IVF consultation appointment. Most people have questions regarding the consent forms. Your questions will be addressed during the appointment.

More information

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services Reference No: Version: 2 Ratified by: EMSCGP006V2 EMSCG Date ratified:

More information

Family Building for Transgender Men and Women

Family Building for Transgender Men and Women Family Building for Transgender Men and Women A Guide to Becoming a Parent PATH2PARENTHOOD path2parenthood.org Are you a transgender man or woman and think you might want to become a parent? If you re

More information

Haringey CCG Fertility Policy April 2014

Haringey CCG Fertility Policy April 2014 Haringey CCG Fertility Policy April 2014 1 SUMMARY This policy describes the clinical pathways and entry criteria for Haringey patients wishing to access NHS funded fertility treatment. 2 RESPONSIBLE PERSON:

More information

Neil Goodman, MD, FACE

Neil Goodman, MD, FACE Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects

More information

Embryo Selection after IVF

Embryo Selection after IVF Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus

More information

Age and Fertility: A Study on Patient Awareness

Age and Fertility: A Study on Patient Awareness JBRA Assisted Reproduction 2016;20(3):99-106 doi: 10.5935/1518-0557.20160024 Original Article Age and Fertility: A Study on Patient Awareness Sara Deatsman 1, Terrie Vasilopoulos 2, Alice Rhoton-Vlasak

More information

Your consent to donating your eggs

Your consent to donating your eggs HFEA WD form (Gender-neutral version) Your consent to donating your eggs About this form This form is produced by the Human Fertilisation and Embryology Authority (HFEA), the UK s independent regulator

More information